Zhejiang Gongdong Medical Technology Co Ltd
SSE:605369
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
25.3051
42.6132
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Zhejiang Gongdong Medical Technology Co Ltd
Accounts Receivables
Zhejiang Gongdong Medical Technology Co Ltd
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Zhejiang Gongdong Medical Technology Co Ltd
SSE:605369
|
Accounts Receivables
ÂĄ223.5m
|
CAGR 3-Years
14%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
||
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
Accounts Receivables
ÂĄ6.3B
|
CAGR 3-Years
9%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
||
Autobio Diagnostics Co Ltd
SSE:603658
|
Accounts Receivables
ÂĄ1.2B
|
CAGR 3-Years
10%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
||
Winner Medical Co Ltd
SZSE:300888
|
Accounts Receivables
ÂĄ768.6m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
||
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Accounts Receivables
ÂĄ620.5m
|
CAGR 3-Years
42%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
||
Intco Medical Technology Co Ltd
SZSE:300677
|
Accounts Receivables
ÂĄ1.3B
|
CAGR 3-Years
18%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
Zhejiang Gongdong Medical Technology Co Ltd
Glance View
Zhejiang Gongdong Medical Technology Co., Ltd. engages in the development and production of disposable medical devices and medical inspection supplies. The company is headquartered in Taizhou, Zhejiang and currently employs 1,348 full-time employees. The company went IPO on 2020-09-16. The firm's main products cover vacuum blood collection systems, laboratory testing consumables, body fluid collection consumables, medical care consumables and pharmaceutical packaging materials. Its products include disposable vacuum blood collection tubes, petri dishes, culture plates, cuvettes, pipette tips, disposable sterile sampling swabs, dispensers, dressing containers and others. The firm's products are applied in clinical diagnosis and nursing, scientific research and testing, pharmaceutical packaging and other fields. The firm distributes its products in the domestic market and to overseas markets, including many countries in North America, Asia, South America, Africa and Europe.
See Also
What is Zhejiang Gongdong Medical Technology Co Ltd's Accounts Receivables?
Accounts Receivables
223.5m
CNY
Based on the financial report for Dec 31, 2023, Zhejiang Gongdong Medical Technology Co Ltd's Accounts Receivables amounts to 223.5m CNY.
What is Zhejiang Gongdong Medical Technology Co Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 5Y
19%
Over the last year, the Accounts Receivables growth was -6%. The average annual Accounts Receivables growth rates for Zhejiang Gongdong Medical Technology Co Ltd have been 14% over the past three years , 19% over the past five years .